Analyst Conference Summaries

Biotechnology Investor Aids

Biomarin Pharmaceuticals
BRMN

conference date: February 23, 2017 @1:30 PM Pacific Time

Pharmacyclics, BioMarin, And Incyte: A Quick Screen [Seeking Alpha, 3/26/2015]

2017
 
 
 
02/23/2017
 
 
 
2016
 Biomarin Q3 not covered
02/25/2016
04/28/2016
08/04/2016
10/27/2016

Biomarin Pharmaceuticals (BRMN) is commercial stage biotechnology company specializing in therapies for rare disorders (orphan drugs).

Biomarin Pharmaceuticals web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 BIND
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 HNSN
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MDVN
 MYL.
 NVDA
 OPXA
 PLX
 REGN
 SGEN
 XLNX
 XLRN
 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.

Copyright 2016 William P. Meyers